Bayraktar Saral, Ö.; Yavuz, A.; Ardıç, Ş.; Yazıcı, T.; Özer Yaman, S.
Clinical Outcomes of COVID-19 Convalescent Plasma According to Treatment Timing and ELISA Antibody Levels: A Real-World Retrospective Cohort Study. Medicina 2026, 62, 1649.
https://doi.org/10.3390/medicina62091649
AMA Style
Bayraktar Saral Ö, Yavuz A, Ardıç Ş, Yazıcı T, Özer Yaman S.
Clinical Outcomes of COVID-19 Convalescent Plasma According to Treatment Timing and ELISA Antibody Levels: A Real-World Retrospective Cohort Study. Medicina. 2026; 62(9):1649.
https://doi.org/10.3390/medicina62091649
Chicago/Turabian Style
Bayraktar Saral, Özlem, Ayla Yavuz, Şenol Ardıç, Tuncay Yazıcı, and Serap Özer Yaman.
2026. "Clinical Outcomes of COVID-19 Convalescent Plasma According to Treatment Timing and ELISA Antibody Levels: A Real-World Retrospective Cohort Study" Medicina 62, no. 9: 1649.
https://doi.org/10.3390/medicina62091649
APA Style
Bayraktar Saral, Ö., Yavuz, A., Ardıç, Ş., Yazıcı, T., & Özer Yaman, S.
(2026). Clinical Outcomes of COVID-19 Convalescent Plasma According to Treatment Timing and ELISA Antibody Levels: A Real-World Retrospective Cohort Study. Medicina, 62(9), 1649.
https://doi.org/10.3390/medicina62091649